Chronic Leukemias Flashcards

1
Q

Plasma cell dyscrasias

A

Neoplastic plasma cells that almost always secrete monoclonal immunoglobulin
- serve as tumor markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most deadly plasma cell dyscrasias

A

Multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

M protein

A

Monoclonal immunoglobulin in reference to a myeloma

  • complete M proteins are very heavy and are restricted to plasma/extracellular fluid. Are also excluded from urine unless kidney is damaged
  • often contain excess immunoglobulin light chains*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Terms used to describe abnormal IGs associated with plasma cell neoplasms

A

Monoclonal gammopathy

Dysproteinemia

Paraproteinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinicopathologic entities associated with M proteins

A

Multiple myeloma

Monoclonal gammopathy of undetermined significance (MGUS)

Primary amyloidosis

Waldenstrom macroglobulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How to differentiate CLL from SLL?

A

Check peripheral blood lymphocyte counts

> 5000 cells/uL = CLL

<5000 cells/uL = SLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Richter transformation

A

Occurs in aggressive forms of CLL

Transform tumor cells into similar to DLBCL’s

Much more aggressive and kill quicker (<1yr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What diseases can produce M proteins?

A

Multiple myeloma

MGUS

Primary amyloidosis

Waldenstrom macroglobulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Multiple myeloma immunophenotype

A

Lyric lesions throughout bone

Numerous plasma cells in bone marrow with cytoplasmic droplets

lots of IgG and IgA (mostly IgA)

Produces bence jones and the above M proteins

High levels of cyclin D1 and D3 genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bence jones proteins

A

Light chains only aggregations generated by plasma cells

Seen in multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CLL/SLL immunophenotype

A

High levels of BCL2

BTK presence

Smudge cells and pro-lymphocyte are present

CD5 and CD20

Trisomy 12 is common as well as the following deletions
11, 13 and 17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hairy cell leukemia immunophenotype

A

B cells w/ pale blue, agranular cytoplasm, hairlike cytoplasmic projections

BRAF activation

CD20, CD11c and CD103

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most immature cell in the myeloid series?

A

Myeloblast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lineage of myeloid series

A

Myeloblast (immature)

Promyelocyte (basophilic cytoplasm w/ azurophilic granules generation)

Myelocytes (specific granules for basophil, neutrophil and eosinophil generate)

Metamyelocyte ( increasing numbers of granules in the cytoplasm

Band cell (elongated nucleus but not lobed yet)

Segmented granulocytes (maturation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the primary myeloproliferative disorders

A

CML

Polycythemia Vera

Primary Myelofibrosis

Essential thrombocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CML immunophenotype

A

T(9;22)

BCR-ABL gene and proteins

Leukocyte count higher than 100,000 cells

Hypercellular megakaryocytic bone marrow

Spleen looks hypertrophic and like red bone marrow

Philadelphia chromosome is present t(9;22)

17
Q

Blast crisis

A

Last and most aggressive stage of CML marked by large amount of blast cells without an accelerated phase

18
Q

Polycythemia Vera (PV) immunophenotype

A

Activating point mutations in JAK2

Absolute increase in red cell mass

Low serum erythropoietin

Hyperceullar bone marrow w/ possible marrow fibrosis

Pancytocytosis

19
Q

Spent phase

A

Phase of PV that resembles primary Myelofibrosis

Needs to be treated with JAK2 inhibitors

20
Q

Treatments for PV

A

Phlebotomy (1st line)

JAK2 (only in spent phase)